ACR-Modified Keyhole-Lympet Hemocyanine antibody
-
- Target
- ACR-Modified Keyhole-Lympet Hemocyanine
- Host
- Mouse
- Clonality
- Monoclonal
- Application
- Immunohistochemistry (IHC)
- Specificity
- Specific for ACR-modified protein (especially FDP-lysine type derivative).
- Purification
- Protein A purified
- Clone
- 5F6
- Isotype
- IgG1 kappa
-
- Application Notes
- Recommended antibody concentration is 0.5-1.0 µg/mL on paraformaldehyde fixed tissue.
- Restrictions
- For Research Use only
-
- Format
- Frozen
- Buffer
- 100 µg/mL antibody in 10mM PBS containing 0.1% NaN3 and 0.5% BSA
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
-
-
Expressions of lipid oxidation markers, N(ε)-hexanoyl lysine and acrolein in cisplatin-induced nephrotoxicity in rats." in: The Journal of veterinary medical science / the Japanese Society of Veterinary Science, Vol. 73, Issue 6, pp. 821-6, (2011) (PubMed).
: "
-
Expressions of lipid oxidation markers, N(ε)-hexanoyl lysine and acrolein in cisplatin-induced nephrotoxicity in rats." in: The Journal of veterinary medical science / the Japanese Society of Veterinary Science, Vol. 73, Issue 6, pp. 821-6, (2011) (PubMed).
-
- Target
- ACR-Modified Keyhole-Lympet Hemocyanine
- Background
- Acrolein (ACR) is a representative carcinogenic aldehyde found ubiquitously in the environment and formed endogenously through oxidation reactions, such as lipid peroxidation and myeloperoxidasecatalyzed amino acid oxidation. ACR is highly reactive aldehyde and reacts with lysine residue in protein. The reaction with ACR and lysine residue leads to the formation of numerous numbers of adducts, such as formyl-dehydropiperidino-lysine (FDP-lysine) type derivative. This antibody is specific for the ACR-modified protein, especially FDP-lysine type derivative.
-